Identified potential biomarkers may predict primary nonresponse to infliximab in patients with ulcerative colitis
Author:
Affiliation:
1. Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China
2. Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan, China
Funder
National Natural Science Foundation of China
Research Fund of Health Commission of Hubei Provincial
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/08916934.2022.2103803
Reference33 articles.
1. Ulcerative colitis
2. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
3. Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis
4. Breaking the therapeutic ceiling in drug development in ulcerative colitis
5. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of the M2 Macrophage-associated Gene THBS2 as a Predictive Marker for Inflammatory Cancer Transformation;Inflammatory Bowel Diseases;2024-07-23
2. Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment;Biomedicine & Pharmacotherapy;2024-04
3. Identification and immunoinfiltration analysis of key genes in ulcerative colitis using WGCNA;PeerJ;2024-02-26
4. Main active components of Ilex rotunda Thunb. protect against ulcerative colitis by restoring the intestinal mucosal barrier and modulating the cytokine-cytokine interaction pathways;Journal of Ethnopharmacology;2024-01
5. Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease;Crohn's & Colitis 360;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3